Nonalcoholic products of a grapes have a wide spectrum of effects which are successfully used at preventive maintenance, treatment and rehabilitation of many diseases. The purpose of the further integrated researches of scientific institutes of the Ministry of health protection of Ukraine and the Ukrainian academy of agrarian sciences, should become development of the recommendation for use of grapes wines in technologies of complex treatment and rehabilitation of patients with diseases of cardio-pulmonary system. http://эноант.рф

1. 1
663.253.41:547.631.4:613.292.001.12/.5:615.834
(Medicus curat, natura sanit).
.
).
: , , , , , ,
, .
Key words: vine, wine, polyphenols, prevention, treatment, rehabilitation, diseases, cardio-
pulmonary system.
: , , , , , ,
, .
Integration of scientific development for creation of modern medical technologies on the
basis of biologically active substances of a grapes (Medicus curat, natura sanit).
Pidaev A.V.
Summary
Nonalcoholic products of a grapes have a wide spectrum of effects which are successfully
used at preventive maintenance, treatment and rehabilitation of many diseases. The purpose of
the further integrated researches of scientific institutes of the Ministry of health protection of
Ukraine and the Ukrainian academy of agrarian sciences, should become development of the
recommendation for use of grapes wines in technologies of complex treatment and rehabilitation
of patients with diseases of cardio-pulmonary system.
-
(Medicus curat, natura sanit).
.
,
, .
,
.
enoant.info,enoant-club.ru

2. 2
.
.
,
.
,
,
.
. ,
,
, .
« ,
».
,
.
.
,
.
,
.
,
,
.
.
,
, .
enoant.info,enoant-club.ru

3. 3
, ,
.
.
. .
: ,
, ,
, ,
. ,
.
–
, .
, ,
.
,
.
,
,
. ,
,
. ,
.
, 30 ,
21-30% ,
,
.
, 30%,
,
.
,
, (Ellison C.R., 2000).
enoant.info,enoant-club.ru

4. 4
: 1-6 ( 130-150 14
) (Gronbaek M. et al., 1994), 2-4 (Muntwyler J et al, 1998;
Gaziano J.M et al, 2000), 1 - 20 (Hoffmeister H et al, 1999), 1-14
(Hart C.L et al, 1999; Yuan J-M et al, 1997), 1-149 (Tsugane S et
al, 1999) 22-32 (Renaud S.C et al, 1999).
6 , 300
, ,
.
300
750 ,
(Di Castelnuovo A et al, 2000).
,
, -
(Ellison C.R.,
2000).
,
, ,
.
,
( , VII , ), ( -
, , ) (ICAM,
VCAM, ). , ,
,
(Meagher E.A., et al., 1999).
, ,
. ,
30 15 ( ).
.
enoant.info,enoant-club.ru

5. 5
, . ,
.
, ,
- , - .
,
, , ,
.
, ,
.
- , , .
,
.
- , , ,
.
. ,
– . ,
,
(Edeas M.A., Lindenbaum A., 2000).
, ,
.
, ,
,
.
, ,
, , ,
.
,
,
. ,
, -
.
enoant.info,enoant-club.ru

6. 6
,
, . :
, , , , ,
, , , , ,
, , , , ,
, , ,
MELAS .
,
,
.
10-20 , .
(Kondo K et al., 1994; Maxwell S. et al.,
1994; Fuhrman B. et al., 1995; Simonetti P. et al., 1995; Carbonneau M-A., et al., 1997; Miyagi
Y., et al., 1997).
».
.
, ,
, ,
,
,
,
.
, .
,
,
.
600 ,
, , ,
, ( ., 1996; .,
., 1996; . , 2001 )
- -
. ,
enoant.info,enoant-club.ru

7. 7
,
.
,
(Fontecave M et al., 1998).
, ,
.
,
, .
.
), ( , ),
( ). , ,
( ,
1990, 2001; . ., 2000; ., 2001; Fontecave M et al., 1998).
,
,
,
.
,
.
.
,
" " .
, , ,
. ,
.
,
( ., 2001; .,
., 2003).
« »,
enoant.info,enoant-club.ru

8. 8
« ».
(18-20 )
" - ", .
1-2 ,
.
,
,
.
.
« » .
, 3000
; 1,25
in vitro;
0,52 ; 0,52
, , ,
, ,
( . , 2000; ., ., 2003; . .
., 2003 ).
" " ,
0,45 .
,
,
,
,
( . , 2001; ., 2001;
. ., 2003).
" "
.
0,25 0,45
, ,
, ,
,
enoant.info,enoant-club.ru

9. 9
,
( . , 2001; .,
2001; . ., 2003).
( ), ,
, . . .
,
. . , "
" " " ( ., 2001).
, ,
.
, , ,
( . , 2001 ; ., 2001;
. ., 2003).
, , ,
, . ,
, ( ),
(Bowry V.W., Stocker R., 1994; Bowry V.W et al., 1995). ,
.
, ,
.
.
,
, ( , ,
, , .),
, .
,
,
, .
enoant.info,enoant-club.ru

10. 10
,
.
-
(Hoffmeister H et al,
1999; Hart C.L et al, 1999; Yuan J-M et al, 1997),
(Ellison C.R., 2000; Renaud S.C et al, 1999; Di Castelnuovo A et al, 2000).
,
, ,
(Gaziano J.M et al., 1993)
,
(Rotondo S et al., 2000; Edeas M.A., Lindenbaum A., 2000).
FAIR CT 97 3261 "Wine & Cardiovascular Disease",
, , ,
, ,
( ).
, , , ,
in vitro, ex vivo
in vivo.
,
(NO) ² .
.
,
, (
, 2- -1 ICAM-1),
.
100 . , ,
100 ,
(Rotondo S et al.,
2000).
,
30 30
, ,
,
enoant.info,enoant-club.ru

11. 11
.
2- -1 LFA1,
(Rotondo
S et al., 2000).
,
( , ),
,
, ,
, .
. ,
. -
, -
(Edeas M.A., Lindenbaum A.,2000).
,
, ,
, , .
, ,
,
, .
,
.
, .
,
,
.
,
,
enoant.info,enoant-club.ru

12. 12
.
, ,
– «Medicus curat, natura sanit».
, ,
.
.
1. ., ., ., .
. // « ».
.- 2001.- 1.- . 30-31.
2. .,
,
,
. :
:
". - , 2003.- .
3-8.
3. ., ., . , ., ., .
:
" ".
: "
:
". - , 2003.- . 55-72.( )
4. ., ., ., ., .., .
« »
. // . . "
:
". - , 2003.- .55-72.( )
5. . . - :
« », 1990. - 24 .
6. . . - : , 2001.- 624 .
7. .
. // . ., .
.- 2001.- 3.- . 40-48.
8. ., ., ., ., .,
., ., ., ., ., .,
., ., ., ., .,
., .
. : "
:
". - , 2003.- . 86-119.
9. ., ., ., . .
.// :
. -
" ". -
: . -2001.- .35-39.( )
enoant.info,enoant-club.ru

13. 13
10. ., ., ., . .
.// :
. -
" ". –
-2001.- .41-45.( )
11. . , " ". //
. - 1996.- 4.- . 34-40.
12. ., ., ., ., .,
. . //
». . - 2000.- 4 .- .25-26.
13. ., .
.//
. - 2.-1996.- . 4-9.
14. Bowry V.W., Stocker R. Tokopherol-mediated peroxidation. The pro-oxidant effect of
vitamin E on the radical-initiated oxidation of human low density lipoprotein.// J Am Chem
Soc.- 1994.- v 115.- pp 6029-6044.
15. Bowry V.W., Mohr D., Cleary J., Stocker R. Prevention of tokopherol-mediated peroxidation
of ubiquinol-10-free human low density lipoprotein.// J Biol Chem.- 1995.-v 270.- pp 5756-
5763.
16. Carbonneau M-A., Leger C.L., Monnier L., Bonnet C., Michel F., Fouret G., Dedieu F.,
Descomps B. Supplementation with wine phenolic compounds increases the antioxidant
capacity of plasma and vitamin E of low- density lipoprotein without changing the
lipoprotein Cu²-oxidizability: possible explanation by phenolic location.// Eur J Clin Nutr/-
1997.-v 51.- pp682-690.
17. Di Castelnuovo A. et al. Wine consumption and vascular risk: a meta-analysis. In: XXVeme
congres mondial de la vigne et du vin. Paris, 19-23 june 2000. - pp 9-16.
18. Edeas M.A., Lindenbaum A. Protective effects of various flavonoids compaunds on HIV
infection. In: XXVeme congres mondial de la vigne et du vin. Paris, 19-23 june 2000. - pp
57-61.
19. Ellison C.R. The "bottom line" - do moderate wine drinkers live longer? In: XXVeme
congres mondial de la vigne et du vin. Paris, 19-23 june 2000. - pp 1-8.
20. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O. Resveratrol, a remarkable
inhibitor of ribonucleotide reductase.// FEBS Lett.- 1998.-16.- 421.- pp. 277 - 279.
21. Fuhrman B., Lavy A., Aviram M. Consumption of red wine with meals reduces the
susceptibility of human plasma and low- density lipoproteins to lipid peroxidation.// Am J
Clin Nutr.-1995.- v 61.- pp.549-554.
22. Gaziano J.M. et al. Moderate alcohol intake, increased levels of high-density lipoprotein and
its subfractions, and decreased risk of myocardial infarction/ // N Engl J Med.- 1993.- v 329.-
pp.1829-1834.
23. Gaziano J.M. et al. Light-to-moderate alcohol consumption and mortality in the Physicians'
Health Study enrollment cohort. // J Am Coll Cardiol.- 2000.- N 35.- pp.95-105.
24. Gronbaek M. et al. Influence of sex, age, body mass index, and smoking on alcohol intake
and mortality.- //BMJ.- 1994.- v 308.- pp.302-306.
25. Hart C.L., Smith G.D., Hole D.J., Hawthorne V.M. Alcohol consumption and mortality from
all causes, coronary heart disease, and stroke: results from a prospective cohort study of
Scottish men with 21 years of follow up. // BMJ.-1999.- v 318.- pp.1725-1729.
26. Hoffmeister H. et al. The relationship between alcohol consumption, health indicators and
mortality in the German population. // Int J Epidemiol.- 1999.- v 28.- pp. 1066-1072.
27. Kondo K., Matsumoto A., Kurata H., Tanahasi H., Koda H., Amachi T., Ikura H. Inhibition
of oxidation of low-density lipoproteins with red wine. // The Lancet.-1994.- v 344.-
pp.1152.
enoant.info,enoant-club.ru

14. 14
28. Maxwell S., Cruikshank A., Thorpe G. Red wine and antioxidant activity in serum.// The
Lancet.-1994.- v 344.- pp.193-194.
29. Meagher E.A., Barry O.P., Burke A., Lucey M.R., Lawson J.A., Rokach J., Fitzgerald G.A.
Alcohol-induced generation of lipid peroxidation products in humans. // J Clin Invest.-1999.-
v 104.- pp 805-813.
30. Miyagi Y., Miwa K., Inoue H. Inhibition of low density lipoprotein oxidation by flavonoids
in red wine and grape juice.// Am J Card.- 1997.- v 80.- pp 1627-1631.
31. Muntwyler J. et al. Mortality and light to moderate alcohol consumption after myocardial
infarction.// Lancet.- 1998.- v 352.- pp.1882-1885.
32. Renaud S.C., Gueguen R., Siest G., Salamon R. Wine, beer, and mortality in middle-aged
men from eastern France. // Arch Intern Med.- 1999.- v. 159.- pp. 1865-1870.
33. Rotondo S., de Gaetano G. Protection from cardiovascular disease by wine and its derived
products: epidemiological evidence and biological mechanisms. In: Mediterranean Diets.
//World Rev Nutr Diet. Basel. Karger.- 2000.- v. 87.- pp-90-113.
34. Simonetti P., Brusamolino A., Pellegrini N., Viani P., Clemente G., Roggi C., Cestaro B.
Evaluation of the effects of alcohol consumption on erythrocyte lipids and vitamins in a
healthy population.// Alcohol: Clin and Exp Res.-1995.- v 19/- pp517-522.
35. Stokley C.S. Advances in Australian research into the potential cardio and cancer protective
properties of wine. In: XXVeme congres mondial de la vigne et du vin. Paris, 19-23 june
2000. - pp 33-41.
36. Tsugane S. et al. Alcohol consumption and all-case and cancer mortality among middle-aged
Japanese men: Seven-year follow-up of the JPHC Study Cohort I. // Am J Emidemiol. -
1999.- v 150.- pp. 1201-1207.
37. Yuan J-M. et al. Follow up study of moderate alcohol consumption and mortality among
middle aged men in Shanghai, China. // BMJ.- 1997.- N 314.- pp 18-23.
enoant.info,enoant-club.ru